Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728116 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
A NA study, sponsored by Morphic Medical.
- Terminated
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01728116 is a NA study that was terminated before completion, run by Morphic Medical. The registered enrollment target is 325 participants.
The verdict
NCT01728116, a NA study, was terminated before completion, sponsored by Morphic Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes
Interventions
- PROCEDURE Sham Procedure
- DEVICE EndoBarrier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01728116
The ClinicalTrials.gov registry entry for NCT01728116 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Morphic Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT01728116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01728116 about?
NCT01728116 is a clinical study titled "Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese". To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes
What is the current status of trial NCT01728116?
This trial is currently terminated. It is a NA study. The enrollment target is 325 participants. The study started on 2012-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01728116?
The interventions under investigation include: Sham Procedure (PROCEDURE), EndoBarrier (DEVICE).
Who is sponsoring clinical trial NCT01728116?
This trial is sponsored by Morphic Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.